Market Introduction
ECG devices monitors and record electrical activity of the heart and the device detects and picks up electrical impulses generated by the polarization and depolarization of cardiac tissue and translate them into waveform. A mobile ECG monitoring device is the complete diagnostic solution for diagnosis of arrhythmia and provides full disclosure ECG signal, data, analysis, reporting, and allows monitoring of heart at anyplace at any time, such as, home. It consists of two divisions, including, the analog signal receiver that reads, amplifies and convert the signal to digital form and the other part is a wireless transmitter that sends the data to storage devices so that it can be analyzed by physicians and medical personnel. It connect with Wi-Fi, Bluetooth, or the internet to mobiles, tablets, among others.
Market Overview and Dynamics
The North America mobile ECG devices market is expected to reach US$ 994.14 million by 2028 from US$ 712.04 million in 2021; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028. The market growth is attributed to technological advancements in portable and handheld ECG devices, rise in the incidence of cardiovascular diseases, increase in geriatric population, and favorable government regulations regarding monitoring devices. However, aspects such as unfavorable reimbursement policies and market saturation restrict the mobile ECG devices market growth in North America.
ECG monitoring is an essential part of the healthcare services for older adults due to which the elderly population is a primary target of mobile ECG monitoring system providers. According to the US Census Bureau, the number of Americans with age 65 and above is anticipated to double from 46 million in 2016 to more than 98 million by 2060, and the share of elderly population in the total population will increase to ~24% from ~15% during this period. With a significant rise in the number of people aged 65 and above, the number of people suffering from CVDs is likely to increase in the coming years as the prevalence of these diseases is associated with aging due to weak immunity among these people. Thus, the demand for mobile and wireless devices, and other technological advancements to ensure improved CVD prevention and control is likely to rise in the future. Therefore, the geriatric population is also prone to arrhythmia, among other aging-related diseases, which is likely to boost the demand for mobile ECG devices for diagnosis and treatment during the forecast period. The ECG systems are the most effective instruments for detecting arrhythmias (abnormal heart rhythm), coronary artery disease, atrial fibrillation, previous heart attack, and other conditions. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, which cause 17.9 million deaths in the world each year; moreover, 30 million people suffer from stroke every year. According to the WHO factsheets, ~17.7 million people died due to CVDs in 2017, of which ~7.4 million mortalities were due to coronary heart disease and 6.7 million were due to stroke. Therefore, the rise in the incidence of cardiovascular diseases and other heart-related conditions is driving mobile ECG device market growth.
The onset of COVID-19 in North America led to the overburdening of healthcare systems, and the delivery of medical care to all patients became a critical challenge in the region. Moreover, a sudden surge in number of infections led to the shortage of emergency health supplies such as ventilators, beds, and oxygen cylinders. To manage the outbreak, governments took preventive measures including total lockdowns and social distancing policies. As the COVID-19 pandemic continues to unfold, medical device companies started facing difficulties in managing their operations. Many companies offering products for cardiac monitoring have their business operations in the US, and the pandemic adversely affected these businesses due to the temporary shutdown of facilities and disturbed operations of suppliers or customers. Moreover, since March 2020, US healthcare authorities framed policies about elective cardiac surgeries. To free up hospital beds for COVID patients, hospitals had to postpone or cancel their fewer essential operations. However, demand for vital sign monitoring devices in the region had substantial impact on the adoption of ECG devices.
Key Market Segments
The North America mobile ECG devices market, based on type, has been segmented into monitoring ECG systems and diagnostic ECG systems. The monitoring ECG systems segment held a larger share of the market in 2021. Moreover, the monitoring ECG systems segment is anticipated to register a higher CAGR in the market during the forecast period due to product innovation, and incumbent usage and high-volume consumption of these products.
The North America mobile ECG devices market, based on application, is segmented into handheld, band, pen, and others. In 2021, the handheld segment held the largest share of the market. Moreover, the segment is also expected register the fastest CAGR in the market during 2021–2028.
The North America mobile ECG devices market, based on end user, is segmented into personal users, hospitals and clinics, and ambulatory services. In 2021, the personal users segment accounted for the largest share of the market. Moreover, the segment is expected to witness the highest CAGR in the market during 2021–2028.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the North America mobile ECG devices market are the Centers for Disease Control and Prevention (CDC), CDC’s Division for Heart Disease and Stroke Prevention (DHDSP), and US Food and Drug Administration.
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of North America mobile ECG devices market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America mobile ECG devices market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America mobile ECG devices market.
NORTH AMERICA MOBILE ECG DEVICES MARKET SEGMENTATION
- Monitoring ECG Systems
- Diagnostics ECG Systems
By Modality
By End Use
By Country
- US
- Canada
- Mexico
Company Profiles
- CardioComm Solutions Inc.
- Koninklijke Philips N.V.
- Bittium Biosignals LTD. (Subsidiary of Bittium Corporation)
- Medtronic
- AliveCor, Inc
- Nihon Kohden Corporation
- EB Neuro S.P.A
- Preventice Solutions
North America Mobile ECG Devices Market Strategic Insights
North America Mobile ECG Devices Market Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 712.04 Million |
| Market Size by 2028 | US$ 994.14 Million |
| CAGR (2021 - 2028) | 4.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Mobile ECG Devices Market Country and Regional Insights
